Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.

16/06/2023
/ Publications
/
Toxicity

Based on data from a registry, clinical outcomes of 174 patients were analyzed in this study. With a median follow-up period 908 days, the 3-year OS rates for...

Proton beam therapy in rectal cancer: A systematic review and meta-analysis.

16/09/2021
/ Publications
/
IMRT
Dosimetry

This review article examined eight original studies with a total of 127 patients. There was significantly less irradiated small bowel with PBT compared to 3DCRT...

Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.

16/06/2022
/ Publications
/
IMRT
IMPT
Dosimetry

This study compared hematologic toxicity in 41 anal cancer patients treated with IMPT (n=14) or IMRT (n=27). This study found all pelvic bone marrow dose...

Proton versus photon radiation therapy: A clinical review.

16/03/2023
/ Publications
/
Clinical Trial

This review summarized comparative clinical outcomes between proton and photon radiotherapy. 63 interventional comparative studies were presented in this...

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.

30/10/2024
/ Publications

This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.

05/11/2024
/ Publications

PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

05/11/2024
/ Publications

Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...

Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy.

05/11/2024
/ Publications

Using data of 133,898 N0M0 prostate cancer cases from the National Cancer Database, this study compared second primary cancer (SPC) probabilities among those...

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.

11/08/2019
/ Publications
/
Pencil Beam Scanning - PBS
Toxicity

This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...